SUBSCRIBE
SUBSCRIBE

Astria Therapeutics

NEWS
Business
BioSpace Movers & Shakers: Astria, Apertura, CytoDyn, IN8bio & More Make Big Moves
New leaders and top executive roles were selected to guide biopharma and life science companies from Apertura Gene Therapy to CytoDyn, Vaccentis AG, Suvoda LLC, IN8bio and more.
July 14, 2022
 · 
9 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Press Releases
BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile
October 15, 2025
 · 
16 min read
Press Releases
Astria Therapeutics to Present at Upcoming CSACI 80th Anniversary Scientific Meeting
October 10, 2025
 · 
1 min read
Press Releases
Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with Hereditary Angioedema
October 9, 2025
 · 
6 min read
Press Releases
Astria Therapeutics to Present at Upcoming 2025 HAEi Regional Conference EMEA
October 6, 2025
 · 
1 min read
Press Releases
Astria Therapeutics Now Enrolling HAE Patients in the European Union for the Phase 3 ALPHA-ORBIT Trial
October 3, 2025
 · 
8 min read
Press Releases
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 2, 2025
October 3, 2025
 · 
1 min read
Press Releases
Astria Therapeutics Announces Positive Initial Results from the Phase 1a Healthy Subject Trial of STAR-0310 at the European Academy of Dermatology and Venereology
September 18, 2025
 · 
9 min read
Press Releases
Astria Therapeutics to Present Initial Data from Phase 1a Trial of STAR-0310 at Upcoming European Academy of Dermatology & Venereology Congress 2025
September 4, 2025
 · 
1 min read
Press Releases
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 3, 2025
September 4, 2025
 · 
1 min read
Press Releases
Astria Therapeutics to Present at Upcoming Cantor Global Healthcare Conference
August 28, 2025
 · 
1 min read
Load More